Grant of Stock options under Niva Bupa ESOP Plan 2024
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Niva Bupa Health Insurance Company granted 12,251,268 employee stock options (ESOPs) to eligible employees under the ESOP Scheme 2024. Each option allows purchase of one equity share of ₹10 face value at ₹72.45 per option (based on March 2026 weighted average trading price). The options can be exercised within 4 years from vesting and are SEBI SBEB Regulations 2021 compliant. Separately, the company appointed two new Non-Executive Directors (Christopher Patrick Carroll as CEO of Bupa Global and Siobhan Djihan Moynihan as CFO of Bupa Global) effective May 15, 2026, and elevated Ankur Kharbanda to Executive Director and Deputy CEO effective May 8, 2026. Two Non-Executive Directors resigned effective May 8, 2026.
The large ESOP grant (12.25 million options) aligns employee interests with shareholders and may impact EPS dilution, though the company notes no immediate dilution as options have not been exercised. Leadership changes bring Bupa Group executives onto the board, signaling stronger parent company oversight.